Autolus

75 articles with Autolus

• Autolus Launches Roadshow for Initial Public Offering

  6/8/2018

  Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies

• Autolus Announces Appointment of Linda Bain to its Board of Directors

  6/8/2018

  Effective prior to the closing of Autolus’ planned initial public offering.

• Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer

  6/8/2018

  Effective prior to the closing of Autolus’ planned initial public offering.

• 

  Three Biotechs Announce IPOs

  6/8/2018

  Three clinical-stage biotechnology companies announced initial public offerings (IPOs) today. Here’s a summary.

• Biotech Startup Autolus Closes $80 Million for Novel Cancer Program

  9/26/2017

• Autolus Announces Initiation Of The Amelia And Alexander Studies For Auto3: Phase I/II Studies In Paediatric ALL and DLBCL

  9/18/2017

• Autolus Announces First-Dose Cohort Completed In APRIL Study Of AUTO2: A Phase I/II Study In Patients With Multiple Myeloma

  9/18/2017

• Autolus Announces Senior Leadership Appointments

  7/18/2017

• Autolus Release: New CAR-T Approach For The Treatment Of T-Cell Lymphomas Presented At The 2016 American Society of Hematology Annual Meeting

  12/5/2016

• Autolus Announces First Data Presentation For An APRIL CAR For Multiple Myeloma At The 2016 American Society of Hematology Annual Meeting

  12/5/2016

• Autolus Announces Oral Presentations For Two Novel CAR-T Therapies At The 2016 American Society of Hematology Annual Meeting

  11/28/2016

• Autolus Appoints Experienced Oncology Clinical Developer, Dr Vijay Peddareddigari, As Chief Medical Officer

  3/21/2016

• Autolus Snags £40 Million Series B

  3/3/2016

• Autolus Appoints Chief Executive Officer—Dr. Christian Itin, Pioneer Of T-Cell Targeting Therapeutics, Takes The Helm Of Europe’s Leading Engineered T-Cell Developer

  3/3/2016

• Autolus Expands Company's Board Of Directors With The Appointments Of John Berriman And Kapil Dhingra

  5/6/2015